News
Videos
Conferences
Events
Resources
Subscribe

|Videos|August 7, 2015

Common Questions/Concerns from Patients

Episodes in this series

EP. 1 The Day in the Life of the Oncology Nurse

EP. 1 The Day in the Life of the Oncology Nurse

EP. 2 Common Questions/Concerns from Patients

EP. 2 Common Questions/Concerns from Patients

EP. 3 Answering the Difficult Questions

EP. 3 Answering the Difficult Questions

EP. 4 Clinical Trials: Pros and Cons

EP. 4 Clinical Trials: Pros and Cons

Newsletter

Stay up to date on cancer updates, research and education

Related Content

Biotin supplements used for cancer-related hair loss may interfere with key blood tests, risking inaccurate results and altered care decisions: © The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James).

Biotin Supplements May Complicate Cancer Care, Research Shows

February 2nd 2026

Dr. Brittany Dulmage explains how biotin can interfere with lab testing during cancer care: © The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James).

Biotin, Lab Interference and Safer Options for Cancer-Related Hair Loss

January 30th 2026

image of woman.

Caregivers Often Overlook Their Own Health While Supporting Patients

ByDr. Tracy Proverbs-Singh

January 29th 2026

As patients with advanced cancer near the end of life, reducing unnecessary medications may help prioritize comfort, quality of life, and symptom relief: © stock.adobe.com

Rethinking Medications at the End of Life for Patients With Advanced Cancer

January 27th 2026

Image of bonnie.

Taking Back the Razor: Choosing Power in the Face of Hair Loss

January 12th 2026

Trending on CURE

Chemo Brain is Real: My Experience with a Clinical Study and What It Can Teach Us

FDA Grants Priority Review to Datroway for Metastatic Triple-Negative Breast Cancer

Doctor Outlines Cervical Cancer Care, Side Effects, HPV Prevention

What is the Goal of Multiple Myeloma Treatment?

FDA Clears Phase 3 Trial of iSCIB1+ for Advanced Melanoma Treatment